BIOCRYST PHARMACEUTICALS INC revenue breakdown overview

BIOCRYST PHARMACEUTICALS INC revenue for the last year amounted to 9.40 B MXN, the most of which — 9.40 B MXN — came from its highest performing source at the moment, Oral Small-molecule and Injectable Protein Therapeutics, the year earlier bringing 5.63 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought BIOCRYST PHARMACEUTICALS INC 8.05 B MXN, and the year before that — 4.90 B MXN.